Skip to content

ICAAC: Switch from AZT or d4T to tenofovir may improve blood fat levels

Non-Hodgkin's lymphoma risk increased with prolonged high HIV viral load

Study finds antiretroviral therapy cost-effective in South African setting

Clinical and immunological benefits lasting at least three years reported by large Kenyan antiretroviral programme

ICAAC: HCV only factor associated with liver problems in patients starting HIV treatment in 2004

ICAAC: Factors unrelated to HIV or side-effects of HIV treatment major cause of illness in French cohort

ICAAC: New treatment for lipid problems shows promise in HIV patients

ICAAC: Moxifloxacin as effective as ethambutol in TB treatment

Advocacy groups demand equal HIV treatment access for injecting drug users